Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2019-07-14 16:37:26 UTC |
---|
Last Updated | 2019-10-01 21:41:39 UTC |
---|
CypComp ID | CC02210 |
---|
Compound Information |
---|
Name | Cerivastatin |
---|
Structure Image | |
---|
InChIKey | SEERZIQQUAZTOL-ANMDKAQQSA-N |
---|
PubChem ID | 446156 |
---|
CypCompound Information |
---|
Set | CypBoM Training Set |
---|
Bonds of Metabolism (BoMs) | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | | | | - <16,H;Hydroxylation;R1>
- <19,H;Hydroxylation;R2>
- <33,32;Cleavage;R3>
- <33,H;Oxidation;R3>
| | | | | - <33,32;Cleavage;R1>
- <33,H;Oxidation;R1>
|
|
---|
References | - Muck W: Clinical pharmacokinetics of cerivastatin. Clin Pharmacokinet. 2000 Aug;39(2):99-116. doi: 10.2165/00003088-200039020-00002. [PubMed:10976657 ]
- Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, Ploschke J, Radtke M: Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved. Drug Metab Dispos. 1997 Mar;25(3):321-31. [PubMed:9172950 ]
|
---|
Download File | CC02210.sdf |
---|